BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27058934)

  • 1. First Approval of Regenerative Medical Products under the PMD Act in Japan.
    Konishi A; Sakushima K; Isobe S; Sato D
    Cell Stem Cell; 2016 Apr; 18(4):434-5. PubMed ID: 27058934
    [No Abstract]   [Full Text] [Related]  

  • 2. Regenerative medicine legislation in Japan for fast provision of cell therapy products.
    Fujita Y; Kawamoto A
    Clin Pharmacol Ther; 2016 Jan; 99(1):26-9. PubMed ID: 26482927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory Frameworks for Gene and Cell Therapies in Japan.
    Maeda D; Yamaguchi T; Ishizuka T; Hirata M; Takekita K; Sato D
    Adv Exp Med Biol; 2015; 871():147-62. PubMed ID: 26374217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Undertested and Overpriced: Japan Issues First Conditional Approval of Stem Cell Product.
    McCabe C; Sipp D
    Cell Stem Cell; 2016 Apr; 18(4):436-7. PubMed ID: 27058935
    [No Abstract]   [Full Text] [Related]  

  • 5. Balancing Safety and Efficacy With Early Availability in the Regulation of Regenerative Medicine Product.
    Fujiwara Y; Maruyama Y; Honda F
    Clin Pharmacol Ther; 2021 May; 109(5):1182-1185. PubMed ID: 32979224
    [No Abstract]   [Full Text] [Related]  

  • 6. Conditional approval: Japan lowers the bar for regenerative medicine products.
    Sipp D
    Cell Stem Cell; 2015 Apr; 16(4):353-6. PubMed ID: 25842975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory Aspects of Cell and Gene Therapy Products: The Japanese Perspective.
    Maruyama Y; Noda S; Okudaira S; Sakurai A; Okura N; Honda F
    Adv Exp Med Biol; 2023; 1430():155-179. PubMed ID: 37526847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Translational research of cell sheet-based myocardial regeneration therapy].
    Miyagawa S
    Nihon Yakurigaku Zasshi; 2016 May; 147(5):269-71. PubMed ID: 27181720
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell Therapy Regulatory Toolkit: an online regulatory resource.
    Culme-Seymour EJ; Davies JL; Hitchcock J; Mason J; Carpenter MK; Mason C
    Regen Med; 2015; 10(5):531-4. PubMed ID: 26237697
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulatory perspectives of Japan.
    Kusakabe T
    Biologicals; 2015 Sep; 43(5):422-4. PubMed ID: 26028474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring innovation in stem cell and regenerative medicine in Japan: the power of the consortium-based approach.
    Munisi HI; Xie Z; Sengoku S
    Regen Med; 2014; 9(4):467-77. PubMed ID: 25159064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacovigilance of Regenerative Medicine Under the Amended Pharmaceutical Affairs Act in Japan.
    Inokuma Y
    Drug Saf; 2017 Jun; 40(6):475-482. PubMed ID: 28299610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Japan to offer fast-track approval path for stem cell therapies.
    Cyranoski D
    Nat Med; 2013 May; 19(5):510. PubMed ID: 23652082
    [No Abstract]   [Full Text] [Related]  

  • 14. Mesenchymal Stem Cells as a Biological Drug for Heart Disease: Where Are We With Cardiac Cell-Based Therapy?
    Sanina C; Hare JM
    Circ Res; 2015 Jul; 117(3):229-33. PubMed ID: 26185208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose tissue and stem/progenitor cells: discovery and development.
    Kapur SK; Dos-Anjos Vilaboa S; Llull R; Katz AJ
    Clin Plast Surg; 2015 Apr; 42(2):155-67. PubMed ID: 25827560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncertain Oversight of Regenerative Medicines in Japan under the ASRM.
    Lysaght T; Sugii S
    Cell Stem Cell; 2016 Apr; 18(4):438-9. PubMed ID: 27058936
    [No Abstract]   [Full Text] [Related]  

  • 17. Industry highlights: Stem cell and regenerative medicine.
    Ilic D
    Regen Med; 2011 Nov; 6(6 Suppl):55-60. PubMed ID: 21999262
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current status of the regulation and development of cell therapy products in Japan].
    Igarashi Y; Sato Y
    Nihon Yakurigaku Zasshi; 2018; 151(6):254-259. PubMed ID: 29887575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of the National Consortium for Regenerative Medicine and National Regenerative Medicine Database in Japan.
    Okada K; Sato Y; Sugiyama D; Sawa Y
    Clin Ther; 2018 Jul; 40(7):1076-1083. PubMed ID: 29958729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Control of graft-versus-host disease].
    Sugita J; Teshima T
    Rinsho Ketsueki; 2014 Feb; 55(2):170-6. PubMed ID: 24598183
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.